Please provide your email address to receive an email when new articles are posted on . Renin-angiotensin-aldosterone system inhibitor use in patients with hypertension and intracranial aneurysm was ...

DALLAS, June 3, 2022 — A multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood pressure lowering medications ...

A nurse performs vital signs monitoring (VSM). A team of researchers analyzed the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on patients with COVID-19 with ...

A multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood pressure lowering medications, reduced the risk of ...

Adding the novel medication baxdrostat to standard care may help manage high blood pressure and delay the progression of ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hypertension is associated with significantly increased mortality in patients with COVID-19, new ...